Badeaux, A. I. & Shi, Y. Emerging roles for chromatin as a signal integration and storage platform. Nat. Rev. Mol. Cell Biol. 14, 211â224 (2013).
Buechler, M. B. et al. Cross-tissue organization of the fibroblast lineage. Nature 593, 575â579 (2021).
Wang, N., Wu, R., Tang, D. & Kang, R. The BET family in immunity and disease. Signal Transduct. Target. Ther. 6, 23 (2021).
Alexanian, M. et al. A transcriptional switch governs fibroblast activation in heart disease. Nature 595, 438â443 (2021).
Filippakopoulos, P. et al. Selective inhibition of BET bromodomains. Nature 468, 1067â1073 (2010).
Anand, P. et al. BET bromodomains mediate transcriptional pause release in heart failure. Cell 154, 569â582 (2013).
Spiltoir, J. I. et al. BET acetyl-lysine binding proteins control pathological cardiac hypertrophy. J. Mol. Cell. Cardiol. 63, 175â179 (2013).
Duan, Q. et al. BET bromodomain inhibition suppresses innate inflammatory and profibrotic transcriptional networks in heart failure. Sci. Transl. Med. https://doi.org/10.1126/scitranslmed.aah5084 (2017).
Antolic, A. et al. BET bromodomain proteins regulate transcriptional reprogramming in genetic dilated cardiomyopathy. JCI Insight 5, e138687 (2020).
Auguste, G. et al. BET bromodomain inhibition attenuates cardiac phenotype in myocyte-specific lamin A/C-deficient mice. J. Clin. Invest. 130, 4740â4758 (2020).
Padmanabhan, A. et al. BRD4 (bromodomain-containing protein 4) interacts with GATA4 (GATA binding protein 4) to govern mitochondrial homeostasis in adult cardiomyocytes. Circulation 142, 2338â2355 (2020).
Korf-Klingebiel, M. et al. Myeloid-derived growth factor protects against pressure overload-induced heart failure by preserving sarco/endoplasmic reticulum Ca2+-ATPase expression in cardiomyocytes. Circulation 144, 1227â1240 (2021).
Reboll, M. R. et al. EMC10 (endoplasmic reticulum membrane protein complex subunit 10) is a bone marrow-derived angiogenic growth factor promoting tissue repair after myocardial infarction. Circulation 136, 1809â1823 (2017).
Dobaczewski, M., Xia, Y., Bujak, M., Gonzalez-Quesada, C. & Frangogiannis, N. G. CCR5 signaling suppresses inflammation and reduces adverse remodeling of the infarcted heart, mediating recruitment of regulatory T cells. Am. J. Pathol. 176, 2177â2187 (2010).
Dick, S. A. et al. Self-renewing resident cardiac macrophages limit adverse remodeling following myocardial infarction. Nat. Immunol. 20, 29â39 (2019).
Dick, S. A. et al. Three tissue resident macrophage subsets coexist across organs with conserved origins and life cycles. Sci. Immunol. 7, eabf7777 (2022).
Nahrendorf, M. et al. The healing myocardium sequentially mobilizes two monocyte subsets with divergent and complementary functions. J. Exp. Med. 204, 3037â3047 (2007).
Epelman, S. et al. Embryonic and adult-derived resident cardiac macrophages are maintained through distinct mechanisms at steady state and during inflammation. Immunity 40, 91â104 (2014).
Bajpai, G. et al. Tissue resident CCR2â and CCR2+ cardiac macrophages differentially orchestrate monocyte recruitment and fate specification following myocardial injury. Circ. Res. 124, 263â278 (2019).
Yona, S. et al. Fate mapping reveals origins and dynamics of monocytes and tissue macrophages under homeostasis. Immunity 38, 79â91 (2013).
Pinto, A. R. et al. An abundant tissue macrophage population in the adult murine heart with a distinct alternatively-activated macrophage profile. PLoS ONE 7, e36814 (2012).
Lee, M., Lee, Y., Song, J., Lee, J. & Chang, S.-Y. Tissue-specific role of CX3CR1 expressing immune cells and their relationships with human disease. Immune Netw. 18, e5 (2018).
Patel, B. et al. CCR2+ monocyte-derived infiltrating macrophages are required for adverse cardiac remodeling during pressure overload. JACC Basic Transl. Sci. 3, 230â244 (2018).
Revelo, X. S. et al. Cardiac resident macrophages prevent fibrosis and stimulate angiogenesis. Circ. Res. 129, 1086â1101 (2021).
Stratton, M. S. et al. Dynamic chromatin targeting of BRD4 stimulates cardiac fibroblast activation. Circ. Res. 125, 662â677 (2019).
Heidt, T. et al. Differential contribution of monocytes to heart macrophages in steady-state and after myocardial infarction. Circ. Res. 115, 284â295 (2014).
Hanna, A., Humeres, C. & Frangogiannis, N. G. The role of Smad signaling cascades in cardiac fibrosis. Cell. Signal. 77, 109826 (2021).
Whyte, W. A. et al. Master transcription factors and mediator establish super-enhancers at key cell identity genes. Cell 153, 307â319 (2013).
Link, V. M. et al. Analysis of genetically diverse macrophages reveals local and domain-wide mechanisms that control transcription factor binding and function. Cell 173, 1796â1809 (2018).
Kuppe, C. et al. Spatial multi-omic map of human myocardial infarction. Nature 608, 766â777 (2022).
Liu, T., Zhang, L., Joo, D. & Sun, S.-C. NF-κB signaling in inflammation. Signal Trans. Target. Ther. 2, 1â9 (2017).
Lighthouse, J. K. et al. Exercise promotes a cardioprotective gene program in resident cardiac fibroblasts. JCI Insight 4, e92098 (2019).
Pinteaux, E. et al. Cell-specific conditional deletion of interleukin-1 (IL-1) ligands and its receptors: a new toolbox to study the role of IL-1 in health and disease. J. Mol. Med. 98, 923â930 (2020).
Frangogiannis, N. G. Transforming growth factor-β in myocardial disease. Nat. Rev. Cardiol. 19, 435â455 (2022).
Amrute, J. M. et al. Targeting immuneâfibroblast cell communication in heart failure. Nature https://doi.org/10.1038/s41586-024-08008-5 (2024).
Ridker, P. M. et al. Antiinflammatory therapy with canakinumab for atherosclerotic disease. New Engl. J. Med. 377, 1119â1131 (2017).
Everett, B. M. et al. Anti-inflammatory therapy with canakinumab for the prevention of hospitalization for heart failure. Circulation 139, 1289â1299 (2019).
Rhee, A. J. & Lavine, K. J. New approaches to target inflammation in heart failure: harnessing insights from studies of immune cell diversity. Annu. Rev. Physiol. 82, 1â20 (2020).
Yona, S. et al. Fate mapping reveals origins and dynamics of monocytes and tissue macrophages under homeostasis. Immunity 38, 1073â1079 (2013).
Li, D., Wu, J., Bai, Y., Zhao, X. & Liu, L. Isolation and culture of adult mouse cardiomyocytes for cell signaling and in vitro cardiac hypertrophy. J. Vis. Exp. https://doi.org/10.3791/51357 (2014).
Bhattacharyya, S., Sathe, A. A., Bhakta, M., Xing, C. & Munshi, N. V. PAN-INTACT enables direct isolation of lineage-specific nuclei from fibrous tissues. PLoS ONE 14, e0214677 (2019).
Xie, Z. et al. Gene set knowledge discovery with Enrichr. Curr. Protoc. 1, e90 (2021).
Granja, J. M. et al. ArchR is a scalable software package for integrative single-cell chromatin accessibility analysis. Nat. Genet. 53, 403â411 (2021).
Heinz, S. et al. Simple combinations of lineage-determining transcription factors prime cis-regulatory elements required for macrophage and B cell identities. Mol. Cell 38, 576â589 (2010).
Padmanabhan, A. et al. A genome-wide CRISPR screen identifies BRD4 as a regulator of cardiomyocyte differentiation. Nat. Cardiovasc. Res. 3, 317â331 (2024).
Zhang, J. et al. Functional cardiac fibroblasts derived from human pluripotent stem cells via second heart field progenitors. Nat. Commun. 10, 2238 (2019).
Gonzalez-Teran, B. et al. Transcription factor protein interactomes reveal genetic determinants in heart disease. Cell 185, 794â814.e30 (2022).
Vagnozzi, R. J. et al. An acute immune response underlies the benefit of cardiac stem cell therapy. Nature 577, 405â409 (2020).
Liao, Y., Smyth, G. K. & Shi, W. The R package Rsubread is easier, faster, cheaper and better for alignment and quantification of RNA sequencing reads. Nucleic Acids Res. 47, e47 (2019).
Robinson, M. D., McCarthy, D. J. & Smyth, G. K. edgeR: a Bioconductor package for differential expression analysis of digital gene expression data. Bioinformatics 26, 139â140 (2010).
Ritchie, M. E. et al. limma powers differential expression analyses for RNA-sequencing and microarray studies. Nucleic Acids Res. 43, e47 (2015).
Winter, G. E. et al. Phthalimide conjugation as a strategy for in vivo target protein degradation. Science 348, 1376â1381 (2015).
